441 related articles for article (PubMed ID: 765128)
1. The development of policy guidelines governing human experimentation in the United States: a case study of public policy-making for science and technology.
Frankel MS
Ethics Sci Med; 1975 May; 2(1):43-59. PubMed ID: 765128
[No Abstract] [Full Text] [Related]
2. The regulation of human experimentation in the United States--a personal odyssey.
Katz J
IRB; 1987; 9(1):1-6. PubMed ID: 11649890
[No Abstract] [Full Text] [Related]
3. Special informed consent requirements are included in protocol review procedures.
Maloney DM
Hum Res Rep; 1995 Jul; 10(7):1-2. PubMed ID: 11654274
[No Abstract] [Full Text] [Related]
4. Federal investigation concludes that institutional review boards are in trouble.
Maloney DM
Hum Res Rep; 1998 Aug; 13(8):1-2. PubMed ID: 11657190
[No Abstract] [Full Text] [Related]
5. The National Commission on IRBs: an evolutionary approach.
Veatch RM
Hastings Cent Rep; 1979 Feb; 9(1):22-8. PubMed ID: 429058
[No Abstract] [Full Text] [Related]
6. Half-full or half-empty? Evaluating IRB performance.
Mishkin B; Ariand N
Prof Ethics Rep; 1998; 11(3):4-7. PubMed ID: 11657925
[No Abstract] [Full Text] [Related]
7. Nondevelopmental research on human subjects: the impact of the recommendations of the National Commission.
Levine RJ
Fed Proc; 1977 Sep; 36(10):2359-64. PubMed ID: 892005
[No Abstract] [Full Text] [Related]
8. Federal report says protection of human subjects is threatened by numerous factors.
Maloney DM
Hum Res Rep; 1996 May; 11(5):1-3. PubMed ID: 11654438
[No Abstract] [Full Text] [Related]
9. Regulating human gene therapy.
Areen J
West VA Law Rev; 1985; 88(2):153-71. PubMed ID: 11655150
[No Abstract] [Full Text] [Related]
10. Protection of human subjects.
United States
Code Fed Regul Shipping; 1982 Oct; Part 46, Sections 46.101 to 46.306():. PubMed ID: 11660819
[No Abstract] [Full Text] [Related]
11. The NIH trials of growth hormone for short stature.
Tauer CA
IRB; 1994 May; 16(3):1-9. PubMed ID: 11659923
[No Abstract] [Full Text] [Related]
12. IRBs and pharmaceutical company funding of research.
Jellinek MS; Levine RJ
IRB; 1982 Oct; 4(8):9-10. PubMed ID: 11651693
[No Abstract] [Full Text] [Related]
13. Ethical issues in clinical neurological research.
Shore D; Berg K; Mullican C
J Calif Alliance Ment Ill; 1994; 5(1):61-2. PubMed ID: 11653329
[No Abstract] [Full Text] [Related]
14. IRBs and epidemiologic research: how inappropriate restrictions hamper studies.
Cann CI; Rothman KJ
IRB; 1984; 6(4):5-7. PubMed ID: 11649562
[No Abstract] [Full Text] [Related]
15. The concept of the IRB and bureaucratic reality: an exchange of letters.
van Eys J; Levine RJ
IRB; 1984; 6(4):8-10. PubMed ID: 11649563
[No Abstract] [Full Text] [Related]
16. DHHS internal policies for reviewing research involving children.
Reatig N
IRB; 1981 Jan; 3(1):1-4. PubMed ID: 11661894
[No Abstract] [Full Text] [Related]
17. Cognitively impaired subjects. American College of Physicians.
Ann Intern Med; 1989 Nov; 111(10):843-8. PubMed ID: 2683918
[No Abstract] [Full Text] [Related]
18. Why HHS should reconsider its proposed exemption for social policy experiments.
Abram MB;
IRB; 1982 May; 4(5):10-2. PubMed ID: 11649408
[No Abstract] [Full Text] [Related]
19. Institutional review boards. A net too thin.
Palca J
Hastings Cent Rep; 1996; 26(3):4. PubMed ID: 8736666
[No Abstract] [Full Text] [Related]
20. Hospital failed on human research policy.
Science; 1998 Nov; 282(5391):1035. PubMed ID: 11645114
[No Abstract] [Full Text] [Related]
[Next] [New Search]
